Salvage treatment for local recurrence of hepatocellular carcinoma after local ablation therapy

Hepatology Research

Volumn 44, Issue 14, 2014, Pages E335-E345

  Imai, Katsunori ^a   Beppu, Toru ^a,b   Chikamoto, Akira ^a   Mima, Kosuke ^a   Okabe, Hirohisa ^a   Hayashi, Hiromitsu ^a   Nitta, Hidetoshi ^a   Ishiko, Takatoshi ^a   Baba, Hideo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Hepatocellular carcinoma; Local ablation therapy; Local recurrence; Radiofrequency ablation; Salvage treatment

Indexed keywords

ALBUMIN;

AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CANCER CONTROL; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DISEASE FREE SURVIVAL; ERYTHROCYTE TRANSFUSION; FEMALE; HOSPITAL MORTALITY; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LUNG FUNCTION; MALE; MORBIDITY; MORTALITY RATE; OPERATION DURATION; OPERATIVE BLOOD LOSS; OVERALL SURVIVAL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SALVAGE THERAPY; TUMOR ABLATION; TUMOR VOLUME;

EID: 84918554137     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12313     Document Type: Article

References (48)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-156.
2. Befeler AS, Hayashi PH, Di Bisceglie AM. Liver transplantation for hepatocellular carcinoma. Gastroenterology 2005; 128: 1752-1764.
3. Borie F, Bouvier AM, Herrero A etal. Treatment and prognosis of hepatocellular carcinoma: a population based study in France. J Surg Oncol 2008; 98: 505-509.
4. Ikai I, Arii S, Okazaki M etal. Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Hepatol Res 2007; 37: 676-691.
5. Lencioni R. Loco-regional treatment of hepatocellular carcinoma. Hepatology 2010; 52: 762-773.
6. Lau WY, Lai EC. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg 2009; 249: 20-25.
7. Lencioni R, Cioni D, Crocetti L, Bartolozzi C. Percutaneous ablation of hepatocellular carcinoma: state-of-the-art. Liver Transpl 2004; 10: S91-97.
8. Omata M, Tateishi R, Yoshida H, Shiina S. Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: ethanol injection therapy and radiofrequency ablation. Gastroenterology 2004; 127: S159-166.
9. Shiina S, Tateishi R, Imamura M etal. Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors. Liver Int 2012; 32: 1434-1442.
10. Lencioni RA, Allgaier HP, Cioni D etal. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228: 235-240.
11. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3cm or less. Gut 2005; 54: 1151-1156.
12. Livraghi T, Giorgio A, Marin G etal. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995; 197: 101-108.
13. Ishii H, Okada S, Nose H etal. Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection. Cancer 1996; 77: 1792-1796.
14. Hong SN, Lee SY, Choi MS etal. Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol 2005; 39: 247-252.
15. Abu-Hilal M, Primrose JN, Casaril A, McPhail MJ, Pearce NW, Nicoli N. Surgical resection versus radiofrequency ablation in the treatment of small unifocal hepatocellular carcinoma. J Gastrointest Surg 2008; 12: 1521-1526.
16. Lam VW, Ng KK, Chok KS etal. Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma. J Am Coll Surg 2008; 207: 20-29.
17. Shiina S, Tateishi R, Arano T etal. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol 2012; 107: 569-577; quiz 578.
18. Takami Y, Ryu T, Wada Y, Saitsu H. Evaluation of intraoperative microwave coagulo-necrotic therapy (MCN) for hepatocellular carcinoma: a single center experience of 719 consecutive cases. J Hepatobiliary Pancreat Surg 2013; 20: 332-341.
19. Itoh S, Ikeda Y, Kawanaka H etal. Efficacy of surgical microwave therapy in patients with unresectable hepatocellular carcinoma. Ann Surg 2011; 18: 3650-3656.
20. Ohmoto K, Yoshioka N, Tomiyama Y etal. Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas. J Gastroenterol Hepatol 2009; 24: 223-227.
21. Lee SM, Won JY, Lee DY etal. Percutaneous cryoablation of small hepatocellular carcinomas using a 17-gauge ultrathin probe. Clin radiol 2011; 66: 752-759.
22. Xu KC, Niu LZ, Zhou Q etal. Sequential use of transarterial chemoembolization and percutaneous cryosurgery for hepatocellular carcinoma. World J Gastroenterol 2009; 15: 3664-3669.
23. Torzilli G, Del Fabbro D, Palmisano A, Marconi M, Makuuchi M, Montorsi M. Salvage hepatic resection after incomplete interstitial therapy for primary and secondary liver tumours. Br J Surg 2007; 94: 208-213.
24. Sugo H, Ishizaki Y, Yoshimoto J, Imamura H, Kawasaki S. Salvage hepatectomy for local recurrent hepatocellular carcinoma after ablation therapy. Ann Surg Oncol 2012; 19: 2238-2245.
25. Masuda T, Beppu T, Ishiko T etal. Intrahepatic dissemination of hepatocellular carcinoma after local ablation therapy. J Hepatobiliary Pancreat Surg 2008; 15: 589-595.
26. Imai K, Beppu T, Chikamoto A etal. Comparison between hepatic resection and radiofrequency ablation as first-line treatment for solitary small-sized hepatocellular carcinoma of 3cm or less. Hepatol Res 2013; 43: 853-864.
27. Kong J, Pan B, Ke S etal. Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1alpha/VEGFA. PloS One 2012; 7: e37266.
28. Koda M, Maeda Y, Matsunaga Y, Mimura K, Murawaki Y, Horie Y. Hepatocellular carcinoma with sarcomatous change arising after radiofrequency ablation for well-differentiated hepatocellular carcinoma. Hepatol Res 2003; 27: 163-167.
29. Ishiko T, Beppu T, Sugiyama S etal. Radiofrequency ablation with hand-assisted laparoscopic surgery for the treatment of hepatocellular carcinoma in the caudate lobe. Surg Laparosc Endosc Percutan Tech 2008; 18: 272-276.
30. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-213.
31. Imai K, Beppu T, Nakayama Y etal. Preoperative prediction of poorly differentiated components in small-sized hepatocellular carcinoma for safe local ablation therapy. J Surg Oncol 2009; 100: 121-126.
32. Livraghi T, Meloni F, Di Stasi M etal. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology 2008; 47: 82-89.
33. Koda M, Murawaki Y, Hirooka Y etal. Complications of radiofrequency ablation for hepatocellular carcinoma in a multicenter study: an analysis of 16346 treated nodules in 13283 patients. Hepatol Res 2012; 42: 1058-1064.
34. Mulier S, Mulier P, Ni Y etal. Complications of radiofrequency coagulation of liver tumours. Br J Surg 2002; 89: 1206-1222.
35. Zhou Y, Zhao Y, Li B etal. Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. BMC Gastroenterol 2010; 10: 78.
36. Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 2005; 242: 158-171.
37. Komorizono Y, Oketani M, Sako K etal. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer 2003; 97: 1253-1262.
38. Yamanaka Y, Shiraki K, Miyashita K etal. Risk factors for the recurrence of hepatocellular carcinoma after radiofrequency ablation of hepatocellular carcinoma in patients with hepatitis C. World J Gastroenterol 2005; 11: 2174-2178.
39. Kei SK, Rhim H, Choi D, Lee WJ, Lim HK, Kim YS. Local tumor progression after radiofrequency ablation of liver tumors: analysis of morphologic pattern and site of recurrence. AJR Am J Roentgenol 2008; 190: 1544-1551.
40. Hori T, Nagata K, Hasuike S etal. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol 2003; 38: 977-981.
41. Lu DS, Raman SS, Limanond P etal. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol 2003; 14: 1267-1274.
42. Patterson EJ, Scudamore CH, Owen DA, Nagy AG, Buczkowski AK. Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann Surg 1998; 227: 559-565.
43. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. The Liver Cancer Study Group of Japan. Cancer 1994; 74: 2772-2780.
44. N'Kontchou G, Mahamoudi A, Aout M etal. Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology 2009; 50: 1475-1483.
45. Tzeng CW, Cooper AB, Vauthey JN, Curley SA, Aloia TA. Predictors of morbidity and mortality after hepatectomy in elderly patients: analysis of 7621 NSQIP patients. HPB (Oxford) 2013. [Epub ahead of print.]
46. Sato M, Tateishi R, Yasunaga H etal. Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54, 145 patients. J Gastroenterol 2012; 47: 1125-1133.
47. Lam VW, Ng KK, Chok KS etal. Incomplete ablation after radiofrequency ablation of hepatocellular carcinoma: analysis of risk factors and prognostic factors. Ann Surg Oncol 2008; 15: 782-790.
48. Mima K, Hayashi H, Imai K etal. High CD44s expression is associated with the EMT expression profile and intrahepatic dissemination of hepatocellular carcinoma after local ablation therapy. J Hepatobiliary Pancreat Sci 2013; 20: 429-434.